Kazuya Sakai

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 17

Top Venues

Blood advances

British journal of haematology

Journal of clinical medicine

Journal of thrombosis and haemostasis : JTH

Nara Medical University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Nara Medical University Apr 01 2016

Japan

Medical staff :: Department of Blood Transfusion Medicine

Publications

Kenki Saito, Kazuya Sakai, Masayuki Kubo, Hidekazu Azumi, Atsushi Hamamura, Shinichi Ochi, Hiroki Amagase, Hisako Kunieda, Yoshiyuki Ogawa, Hideo Yagi, Masanori Matsumoto
Persistent ADAMTS13 Inhibitor Delays Recovery of ADAMTS13 activity in Caplacizumab-Treated Japanese iTTP Patients. Blood advances (2024)
Kenki Saito, Kazuya Sakai, Masayuki Kubo, Hidekazu Azumi, Atsushi Hamamura, Shinichi Ochi, Hiroki Amagase, Hisako Kunieda, Yoshiyuki Ogawa, Hideo Yagi, Masanori Matsumoto
Persistent ADAMTS13 inhibitor delays recovery of ADAMTS13 activity in caplacizumab-treated Japanese patients with iTTP. Blood advances 8 (9) (2024)
Masahito Uchihara, Kazuya Sakai, Koki Shibata, Kenki Saito, Bernhard Lämmle, Masanori Matsumoto
Immune-mediated thrombotic thrombocytopenic purpura with ischaemic cerebral infarction preceding onset of thrombocytopenia and microangiopathic haemolytic anaemia: A case report. British journal of haematology (2024)
Kenki Saito, Kazuya Sakai, Masayuki Kubo, Hidekazu Azumi, Atsushi Hamamura, Shinichi Ochi, Hiroki Amagase, Hisako Kunieda, Yoshiyuki Ogawa, Hideo Yagi, Masanori Matsumoto
Persistent ADAMTS13 Inhibitor Delays Recovery of ADAMTS13 activity in Caplacizumab-Treated Japanese iTTP Patients. Blood advances (2024)
Yoshitaka Zaimoku, Kazuya Sakai, Noriaki Tsuji, Kazuyoshi Hosomichi, Shinya Yamada, Dung Cao Tran, Miku Kobayashi, Ayana Sugiyama, Kouyuki Hirayasu, Hiroki Mizumaki, Ken Ishiyama, Rikinari Hanayama, Yoshiaki Tomiyama, Shinji Nakao
Haematopoietic regeneration by HLA-A*0206-deficient clones in severe aplastic anaemia without definitive immunosuppressive treatment. British journal of haematology (2024)
Kenki Saito, Kazuya Sakai, Masayuki Kubo, Hidekazu Azumi, Atsushi Hamamura, Shinichi Ochi, Hiroki Amagase, Hisako Kunieda, Yoshiyuki Ogawa, Hideo Yagi, Masanori Matsumoto
Persistent ADAMTS13 inhibitor delays recovery of ADAMTS13 activity in caplacizumab-treated Japanese patients with iTTP. Blood advances 8 (9) (2024)
Kenki Saito, Kazuya Sakai, Masayuki Kubo, Hidekazu Azumi, Atsushi Hamamura, Shinichi Ochi, Hiroki Amagase, Hisako Kunieda, Yoshiyuki Ogawa, Hideo Yagi, Masanori Matsumoto
Persistent ADAMTS13 Inhibitor Delays Recovery of ADAMTS13 activity in Caplacizumab-Treated Japanese iTTP Patients. Blood advances (2024)
Kenki Saito, Kazuya Sakai, Masayuki Kubo, Hidekazu Azumi, Atsushi Hamamura, Shinichi Ochi, Hiroki Amagase, Hisako Kunieda, Yoshiyuki Ogawa, Hideo Yagi, Masanori Matsumoto
Persistent ADAMTS13 inhibitor delays recovery of ADAMTS13 activity in caplacizumab-treated Japanese patients with iTTP. Blood advances 8 (9) (2024)
Kazuya Sakai, Masanori Matsumoto
Clinical Manifestations, Current and Future Therapy, and Long-Term Outcomes in Congenital Thrombotic Thrombocytopenic Purpura. Journal of clinical medicine 12 (10) (2023)
Quintijn Bonnez, Kazuya Sakai, Karen Vanhoorelbeke
ADAMTS13 and Non-ADAMTS13 Biomarkers in Immune-Mediated Thrombotic Thrombocytopenic Purpura. Journal of clinical medicine 12 (19) (2023)
Kazuya Sakai, Masanori Matsumoto, Laure de Waele, Charlotte Dekimpe, Eriko Nakamura, Masayuki Kubo, Claudia Tersteeg, Simon F De Meyer, Karen Vanhoorelbeke
ADAMTS13 conformation and immunoprofiles in Japanese patients with immune-mediated thrombotic thrombocytopenic purpura. Blood advances (2022)
Masayuki Kubo, Kazuya Sakai, Masaki Hayakawa, Hirokazu Kashiwagi, Hideo Yagi, Yoshinobu Seki, Atsushi Hasegawa, Haruyuki Tanaka, Itsuto Amano, Yoshiaki Tomiyama, Masanori Matsumoto
Increased cleavage of von Willebrand factor by ADAMTS13 may contribute strongly to acquired von Willebrand syndrome development in patients with essential thrombocythemia. Journal of thrombosis and haemostasis : JTH 20 (7) (2022)
Kaori Uchino, Kazuya Sakai, Saki Shinohara, Akifumi Matsuhisa, Yusuke Iida, Yuta Nakano, Saori Matsumura, Jo Kanasugi, Soichi Takasugi, Ayano Nakamura, Tomohiro Horio, Satsuki Murakami, Shohei Mizuno, Hidesuke Yamamoto, Ichiro Hanamura, Masanori Matsumoto, Akiyoshi Takami
Successful preventive treatment with cyclosporine in a patient with relapsed/refractory immune-mediated thrombotic thrombocytopenic purpura: a case report and review of the literature. International journal of hematology 116 (2) (2022)
Kazuya Sakai, Yoshihiro Fujimura, Toshiyuki Miyata, Ayami Isonishi, Koichi Kokame, Masanori Matsumoto
Current prophylactic plasma infusion protocols do not adequately prevent long-term cumulative organ damage in the Japanese congenital thrombotic thrombocytopenic purpura cohort. British journal of haematology 194 (2) (2021)
Kazuya Sakai, Yoshihiro Fujimura, Yasuyuki Nagata, Satoshi Higasa, Masato Moriyama, Ayami Isonishi, Mutsuko Konno, Michiko Kajiwara, Yoshiyuki Ogawa, Shigehiko Kaburagi, Tomoko Hara, Koichi Kokame, Toshiyuki Miyata, Kinta Hatakeyama, Masanori Matsumoto
Success and limitations of plasma treatment in pregnant women with congenital thrombotic thrombocytopenic purpura. Journal of thrombosis and haemostasis : JTH 18 (11) (2020)
Kazuya Sakai
Long-term cognitive impairments following recovery in the patients with immune-mediated thrombotic thrombocytopenic purpura. British journal of haematology 191 (5) (2020)
Kazuya Sakai, Akane Ueda, Masaaki Hasegawa, Yasunori Ueda
Efficacy and safety of interferon alpha for essential thrombocythemia during pregnancy: two cases and a literature review. International journal of hematology 108 (2) (2017)

Kazuya Sakai.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Kazuya Sakai